about
Feature Specific Quantile Normalization Enables Cross-Platform Classification of Molecular Subtypes using Gene Expression Data.Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.Mycophenolate mofetil treatment of systemic sclerosis reduces myeloid cell numbers and attenuates the inflammatory gene signature in skin.Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skinA Machine Learning Classifier for Assigning Individual Patients with Systemic Sclerosis to Intrinsic Molecular SubsetsBioMethyl: An R package for Biological Interpretation of DNA Methylation DataGlobal skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profileAbatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
P50
Q47557497-0DD6E1BB-0B88-4FDA-9A36-7FF1DFC7F720Q48121915-050D5335-34E0-49AC-A44C-79A61E5D84A8Q49391534-29B07124-00A1-40CF-A7C4-6E8F19FF92B8Q61798347-B8DD9A9E-7D76-42D7-AAB3-F4B60CAE00C9Q64112404-E71D3792-86BD-4C1F-BDB5-69E0DEDAFBD2Q64115273-D3203A5F-2A65-42DD-A8AD-65745B42D4CEQ91450711-A0E48945-10C6-47E7-B216-1AC8270A6459Q92163669-FED71980-C1AC-499B-B691-DCAD64A306D2
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
promovendus
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Jennifer M Franks
@ast
Jennifer M Franks
@en
Jennifer M Franks
@es
Jennifer M Franks
@nl
type
label
Jennifer M Franks
@ast
Jennifer M Franks
@en
Jennifer M Franks
@es
Jennifer M Franks
@nl
prefLabel
Jennifer M Franks
@ast
Jennifer M Franks
@en
Jennifer M Franks
@es
Jennifer M Franks
@nl
P106
P21
P31
P496
0000-0003-2400-5431